Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors—implications for early Myasthenia gravis treatment.

Marketa Komloova, Kamil Musilek, Anna Horova, Ondrej Holas, Vlastimil Dohnal, Frank J Gunn-Moore, Kamil Kuca

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)
Original languageEnglish
Pages (from-to)2505-2509
JournalBioorganic and Medicinal Chemistry Letters
Volume21
Publication statusPublished - 2011

Cite this